Related references
Note: Only part of the references are listed.An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
Tanja A. Gruber et al.
CANCER CELL (2012)
Distinct and Dynamic Requirements for mTOR Signaling in Hematopoiesis and Leukemogenesis
Alex Kentsis et al.
CELL STEM CELL (2012)
Temporal Changes in PTEN and mTORC2 Regulation of Hematopoietic Stem Cell Self-Renewal and Leukemia Suppression
Jeffrey A. Magee et al.
CELL STEM CELL (2012)
Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
Sebastien Malinge et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes
Zhi-Jian Liu et al.
BLOOD (2011)
Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification
Melanie G. Cornejo et al.
BLOOD (2011)
AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias
Stephen M. Sykes et al.
CELL (2011)
Stem cell gene expression programs influence clinical outcome in human leukemia
Kolja Eppert et al.
NATURE MEDICINE (2011)
Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome
Ashley P. Ng et al.
BLOOD (2010)
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice
Michael G. Kharas et al.
BLOOD (2010)
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
Nicolas Chapuis et al.
BLOOD (2010)
Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis
Jan-Henning Klusmann et al.
GENES & DEVELOPMENT (2010)
TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
Kazuhito Naka et al.
NATURE (2010)
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
Sebastien Malinge et al.
BLOOD (2009)
ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells
Monika J. Stankiewicz et al.
BLOOD (2009)
Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis
Anindita Roy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
ERG Is a Megakaryocytic Oncogene
Samira Salek-Ardakani et al.
CANCER RESEARCH (2009)
Trisomy 21 enhances human fetal erythro-megakaryocytic development
Stella T. Chou et al.
BLOOD (2008)
Activating mutations in human acute megakaryoblastic leukemia
Sebastien Malinge et al.
BLOOD (2008)
FoxO transcription factors and stem cell homeostasis: Insights from the hematopoietic system
Zuzana Tothova et al.
CELL STEM CELL (2007)
Foxo3a is essential for maintenance of the hematopoietic stem cell pool
Kana Miyamoto et al.
CELL STEM CELL (2007)
Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells
Satoshi Yamazaki et al.
EMBO JOURNAL (2006)
Activating alleles of JAK3 in acute megakaryoblastic leukemia
Denise K. Walters et al.
CANCER CELL (2006)
Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation
H Raslova et al.
BLOOD (2006)
Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development
AG Muntean et al.
BLOOD (2005)
Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1
Z Li et al.
NATURE GENETICS (2005)
Share Paper
